Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (104614) 104614
Publication (8106) 8106
Newspaper Article (1732) 1732
Newsletter (1239) 1239
Book Review (1078) 1078
Book Chapter (935) 935
Conference Proceeding (197) 197
Dissertation (163) 163
Book / eBook (146) 146
Magazine Article (110) 110
Trade Publication Article (41) 41
Government Document (30) 30
Reference (22) 22
Web Resource (20) 20
Data Set (15) 15
Paper (8) 8
Transcript (6) 6
Presentation (2) 2
Report (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (67099) 67099
index medicus (37268) 37268
male (32476) 32476
animals (29658) 29658
female (28405) 28405
middle aged (18305) 18305
hematology (17139) 17139
adult (16560) 16560
platelets (15710) 15710
blood platelets (13094) 13094
aged (12844) 12844
blood platelets - metabolism (10739) 10739
mice (9628) 9628
platelet aggregation - drug effects (9406) 9406
peripheral vascular disease (9356) 9356
blood platelets - drug effects (8950) 8950
cell biology (8402) 8402
biochemistry & molecular biology (7806) 7806
platelet aggregation (7765) 7765
analysis (7632) 7632
activation (7230) 7230
rats (7150) 7150
cardiac & cardiovascular systems (6992) 6992
blood platelets - physiology (6890) 6890
thrombosis (6706) 6706
pharmacology & pharmacy (6697) 6697
research (6591) 6591
platelet count (6538) 6538
risk factors (6117) 6117
platelet aggregation inhibitors - therapeutic use (6043) 6043
time factors (5984) 5984
expression (5910) 5910
inflammation (5701) 5701
cells, cultured (5659) 5659
surgery (5528) 5528
blood (5517) 5517
platelet-derived growth factor (5511) 5511
platelet activation (5211) 5211
aspirin (5197) 5197
aggregation (5103) 5103
treatment outcome (5048) 5048
proteins (5019) 5019
platelet (4953) 4953
care and treatment (4670) 4670
platelet aggregation inhibitors - pharmacology (4366) 4366
health aspects (4328) 4328
oncology (4321) 4321
medicine (4241) 4241
clopidogrel (4175) 4175
article (4110) 4110
disease (4105) 4105
adolescent (4101) 4101
in vitro techniques (4081) 4081
cells (4075) 4075
signal transduction (4036) 4036
immunology (4028) 4028
medicine, research & experimental (3897) 3897
in-vitro (3850) 3850
physiological aspects (3846) 3846
dose-response relationship, drug (3831) 3831
inhibition (3705) 3705
research article (3590) 3590
plasma (3569) 3569
medicine & public health (3534) 3534
flow cytometry (3502) 3502
ticlopidine - analogs & derivatives (3487) 3487
atherosclerosis (3443) 3443
aged, 80 and over (3402) 3402
cancer (3389) 3389
platelet function tests (3378) 3378
thrombin (3315) 3315
phosphorylation (3294) 3294
patients (3280) 3280
mortality (3272) 3272
collagen (3239) 3239
prospective studies (3213) 3213
risk (3165) 3165
multidisciplinary sciences (3150) 3150
hemostasis (3024) 3024
abridged index medicus (2994) 2994
physiology (2993) 2993
studies (2993) 2993
therapy (2955) 2955
in-vivo (2942) 2942
gene expression (2907) 2907
endothelium (2886) 2886
neurosciences (2846) 2846
platelet-rich plasma (2843) 2843
coagulation (2795) 2795
myocardial-infarction (2776) 2776
medical research (2758) 2758
blood platelets - cytology (2745) 2745
thrombocytopenia (2722) 2722
disease models, animal (2710) 2710
receptor (2709) 2709
cardiovascular disease (2677) 2677
angiogenesis (2674) 2674
platelet aggregation inhibitors - administration & dosage (2654) 2654
retrospective studies (2640) 2640
medicine, general & internal (2639) 2639
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (83) 83
Online Resources - Online (21) 21
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Dentistry (Harry R Abbott) - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Gerstein Science - Theses (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
University Archives - Archives (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (105252) 105252
German (927) 927
Japanese (566) 566
Russian (457) 457
French (395) 395
Chinese (367) 367
Polish (185) 185
Italian (165) 165
Spanish (165) 165
Turkish (55) 55
Korean (53) 53
Portuguese (41) 41
Czech (30) 30
Hungarian (27) 27
Swedish (17) 17
Dutch (14) 14
Danish (12) 12
Hebrew (11) 11
Romanian (11) 11
Serbian (10) 10
Croatian (7) 7
Lithuanian (7) 7
Slovak (7) 7
Persian (6) 6
Bulgarian (5) 5
Norwegian (4) 4
Ukrainian (3) 3
Finnish (2) 2
Slovenian (2) 2
Arabic (1) 1
Indonesian (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function
by HAYWARD, C. P. M and HARRISON, P and CATTANEO, M and ORTEL, T. L and RAO, A. K and Platelet Physiology Subcomm Sci St and Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 02/2006, Volume 4, Issue 2, pp. 312 - 319
Background: Closure time (CT), measured by platelet function analyzer (PFA‐100®) device, is now available to the clinical laboratory as a possible alternative... 
PFA-100(TM) SYSTEM | PERCUTANEOUS CORONARY INTERVENTION | IN-VITRO | PRIMARY HEMOSTASIS | TEMPLATE BLEEDING-TIME | VON-WILLEBRAND-DISEASE | HIGH-SHEAR STRESS | PERIPHERAL VASCULAR DISEASE | HEALTHY-VOLUNTEERS | DYSFUNCTION | HEMATOLOGY | ASPIRIN RESISTANCE | Liver Diseases - blood | Coronary Disease - blood | Hemorrhage - therapy | Cardiopulmonary Bypass - adverse effects | Humans | Blood Platelet Disorders - congenital | Hemorrhage - blood | Blood Platelets - physiology | Blood Platelet Disorders - blood | Blood Platelet Disorders - diagnosis | Platelet Count | Uremia - blood | Platelet Aggregation Inhibitors - pharmacology | Platelet Function Tests - instrumentation | Blood Platelets - drug effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization: The TRILOGY ACS Platelet Function Substudy
by Gurbel, Paul A and Erlinge, David and Ohman, E. Magnus and Neely, Benjamin and Neely, Megan and Goodman, Shaun G and Huber, Kurt and Chan, Mark Y and Cornel, Jan H and Brown, Eileen and Zhou, Chunmei and Jakubowski, Joseph A and White, Harvey D and Fox, Keith A. A and Prabhakaran, Dorairaj and Armstrong, Paul W and Tantry, Udaya S and Roe, Matthew T and TRILOGY ACS Platelet Function Subs and TRILOGY ACS Platelet Function Substudy Investigators and Kardiologi and Cardiology and Lund University and Lunds universitet
JAMA, ISSN 0098-7484, 11/2012, Volume 308, Issue 17, pp. 1785 - 1794
CONTEXT The relationship of platelet function testing measurements with outcomes in patients with acute coronary syndromes (ACS) initially managed medically... 
TRIAL | REACTIVITY | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Body Weight | Age Factors | Ticlopidine - therapeutic use | Humans | Acute Coronary Syndrome - physiopathology | Male | Aspirin - administration & dosage | Angina, Unstable - drug therapy | Platelet Function Tests | Myocardial Ischemia - physiopathology | Female | Myocardial Infarction - physiopathology | Platelet Aggregation Inhibitors - therapeutic use | Stroke | Treatment Outcome | Piperazines - therapeutic use | Myocardial Ischemia - drug therapy | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - drug therapy | Myocardial Infarction - drug therapy | Angina, Unstable - physiopathology | Aged | Platelet Activation - drug effects | Clinical trials | Blood platelets | Acute coronary syndromes | Drug therapy | Patients | Clinical outcomes | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: Results from the platelet inhibition and patient outcomes (PLATO) trial
by James, Stefan and Budaj, Andrzej and Aylward, Philip and Buck, Kristen K and Cannon, Christopher P and Cornel, Jan H and Harrington, Robert A and Horrow, Jay and Katus, Hugo and Keltai, Matyas and Lewis, Basil S and Parikh, Keyur and Storey, Robert F and Szummer, Karolina and Wojdyla, Daniel and Wallentin, Lars and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala kliniska forskningscentrum (UCR)
Circulation, ISSN 0009-7322, 09/2010, Volume 122, Issue 11, pp. 1056 - 1067
Background-Reduced renal function is associated with a poorer prognosis and increased bleeding risk in patients with acute coronary syndromes and may therefore... 
clopidogrel | mortality | renal function | acute coronary syndrome | bleeding | myocardial infarction | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | MYOCARDIAL-INFARCTION | INSUFFICIENCY | RISK | CLASSIFICATION | IMPACT | EPTIFIBATIDE | PERIPHERAL VASCULAR DISEASE | DYSFUNCTION | CHRONIC KIDNEY-DISEASE | Kidney Diseases - physiopathology | Outcome Assessment (Health Care) | Ticlopidine - therapeutic use | Humans | Middle Aged | Acute Coronary Syndrome - physiopathology | Male | Adenosine - adverse effects | Adenosine - therapeutic use | Receptors, Purinergic P2Y12 | Ticlopidine - adverse effects | Cardiovascular Diseases - epidemiology | Female | Kidney Diseases - complications | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Cardiovascular Diseases - physiopathology | Hemorrhage - epidemiology | Hemorrhage - physiopathology | Risk Factors | Kaplan-Meier Estimate | Purinergic P2 Receptor Antagonists | Treatment Outcome | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - drug therapy | Adenosine - analogs & derivatives | Aged | Chronic Disease | Aggregation | Usage | Blood platelets | Patient outcomes | Clopidogrel | Drug therapy | Comparative analysis | Health aspects | Heart attack | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | MEDICINE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A novel variant glanzmann thrombasthenia due to co-inheritance of a loss-and a gain-of-function mutation of ITGB3: Evidence of a dominant effect of gain-of-function mutations
by Bury, Loredana and Zetterberg, Eva and Leinøe, Eva B and Falcinelli, Emanuela and Marturano, Alessandro and Manni, Giorgia and Nurden, Alan T and Gresele, Paolo
Haematologica, ISSN 0390-6078, 06/2018, Volume 103, Issue 6, pp. e259 - e263
PLATELET DYSFUNCTION | ACTIVATION | DOMAIN | INTEGRIN | MACROTHROMBOCYTOPENIA | PHENOTYPE | HEMATOLOGY | Loss of Function Mutation | Genetic Association Studies | Humans | Erythrocyte Indices | Phenotype | Thrombasthenia - diagnosis | Genes, Dominant | Blood Platelets - metabolism | DNA Mutational Analysis | Pedigree | Thrombasthenia - genetics | Blood Platelets - ultrastructure | Alleles | Platelet Function Tests | Biomarkers | Adult | Female | Integrin beta3 - genetics | Gain of Function Mutation | Amino Acid Substitution | Online Only | Clinical Medicine | Hematologi | Medical and Health Sciences | Hematology | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Platelet function
: assessment, diagnosis, and treatment
by Quinn, Martin, 1968 and Fitzgerald, Desmond, 1953
2005, Contemporary cardiology, ISBN 1588292444, xi, 397
A cutting-edge review of the latest findings on the complexities of platelet function and the various means of inhibiting platelet clot formation. The authors... 
physiopathology | Blood platelets | therapy | physiology | Diagnosis | Blood platelet disorders | Examination | Clinical & internal medicine | Medicine & Public Health | Cardiology
Book
Details down arrow
6. Full Text Platelet function following trauma; A multiple electrode aggregometry study
by Solomon, Cristina and Traintinger, Stefan and Ziegler, Bernhard and Hanke, Alexander and Rahe-Meyer, Niels and Voelckel, Wolfgang and Schöchl, Herbert
Thrombosis and Haemostasis, ISSN 0340-6245, 2011, Volume 106, Issue 2, pp. 322 - 330
Platelets play a central role in coagulation. Currently, information on platelet function following trauma is limited. We performed a retrospective analysis of... 
Acquired coagulation disorders | Haemostasis | Acquired | Platelet pathology/inherited | MANAGEMENT | CONTROL RESUSCITATION | COAGULOPATHY | REPLACEMENT | WHOLE-BLOOD AGGREGOMETRY | CONCENTRATES TRANSFUSION | FIBRINOGEN CONCENTRATE | haemostasis | platelet pathology / inherited | CARDIAC-SURGERY | MAJOR TRAUMA | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | acquired | AGGREGATION | Thrombelastography | Platelet Function Tests - methods | Wounds and Injuries - blood | Humans | Middle Aged | Austria - epidemiology | Trauma Centers | Male | Peptide Fragments - pharmacology | Adenosine Diphosphate - pharmacology | Injury Severity Score | Electrodes | Wounds and Injuries - mortality | Platelet Count | Adult | Female | Platelet Function Tests - instrumentation | Collagen - pharmacology | Platelet Aggregation - drug effects | Retrospective Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: The timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study
by Mahla, Elisabeth and Suarez, Thomas A and Bliden, Kevin P and Rehak, Peter and Metzler, Helfried and Sequeira, Alejandro J and Cho, Peter and Sell, Jeffery and Fan, John and Antonino, Mark J and Tantry, Udaya S and Gurbel, Paul A
Circulation: Cardiovascular Interventions, ISSN 1941-7640, 04/2012, Volume 5, Issue 2, pp. 261 - 269
Background-Aspirin and clopidogrel therapy is associated with a variable bleeding risk in patients undergoing coronary artery bypass graft surgery (CABG). We... 
Antiplatelet therapy | Cardiopulmonary bypass | Bleeding | ISCHEMIC EVENTS | CARDIAC & CARDIOVASCULAR SYSTEMS | bleeding | PRACTICE GUIDELINES | MYOCARDIAL-INFARCTION | antiplatelet therapy | RANDOMIZED CONTROLLED-TRIAL | ORAL ANTIPLATELET THERAPY | CARDIAC-SURGERY | cardiopulmonary bypass | BLOOD-TRANSFUSION | OUTCOMES | ST-SEGMENT ELEVATION | INTERVENTION | Thrombelastography | Ticlopidine - therapeutic use | Humans | Middle Aged | Postoperative Hemorrhage - diagnosis | Postoperative Hemorrhage - epidemiology | Male | Blood Transfusion - statistics & numerical data | Chest Tubes | Preoperative Care | Ticlopidine - analogs & derivatives | Drainage - statistics & numerical data | Postoperative Hemorrhage - drug therapy | Watchful Waiting - methods | Platelet Function Tests | Coronary Artery Bypass | Female | Aged | Practice Guidelines as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C192 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration. A Systematic Meta-Analysis
by Hulot, Jean-Sébastien and Collet, Jean-Philippe and Silvain, Johanne and Pena, Ana and Bellemain-Appaix, Anne and Barthélémy, Olivier and Cayla, Guillaume and Beygui, Farzin and Montalescot, Gilles
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2010, Volume 56, Issue 2, pp. 134 - 143
Objectives: The aim of this study was to assess the association between the loss-of-function cytochrome P450 2C19 (CYP2C19)*2 variant (10 studies, 11,959... 
antiplatelet drugs | proton pump inhibitors | genetics | RESPONSIVENESS | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | STENT THROMBOSIS | CORONARY | AMERICAN-COLLEGE | OMEPRAZOLE | DUAL ANTIPLATELET THERAPY | FUNCTION POLYMORPHISM | ASSOCIATION | PLATELET REACTIVITY | Myocardial Ischemia - chemically induced | Humans | Risk Factors | Ticlopidine - analogs & derivatives | Proton Pump Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Sensitivity and Specificity | Alleles | Ticlopidine - adverse effects | Cytochrome P-450 Enzyme System - genetics | Ticlopidine - administration & dosage | Coronary Thrombosis - etiology | Myocardial Ischemia - mortality | Stents | Platelet Aggregation Inhibitors - adverse effects | Studies | Confidence intervals | Stroke | Heart attacks | Publications | Metabolites | Mortality | Coronary vessels | Cardiovascular disease | Drug therapy | Meta-analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention: The GRAVITAS Randomized Trial
by Price, Matthew J and Berger, Peter B and Teirstein, Paul S and Tanguay, Jean-François and Angiolillo, Dominick J and Spriggs, Douglas and Puri, Sanjeev and Robbins, Mark and Garratt, Kirk N and Bertrand, Olivier F and Stillabower, Michael E and Aragon, Joseph R and Kandzari, David E and Stinis, Curtiss T and Lee, Michael S and Manoukian, Steven V and Cannon, Christopher P and Schork, Nicholas J and Topol, Eric J and GRAVITAS Investigators, for the and GRAVITAS Investigators
JAMA, ISSN 0098-7484, 03/2011, Volume 305, Issue 11, pp. 1097 - 1105
CONTEXT High platelet reactivity while receiving clopidogrel has been linked to cardiovascular events after percutaneous coronary intervention (PCI), but a... 
MEDICINE, GENERAL & INTERNAL | OF-CARE ASSAY | RESPONSIVENESS | IMPACT | INHIBITION | GENOTYPE | REACTIVITY | POLYMORPHISM | ASPIRIN | ANTIPLATELET THERAPY | ARTERY-DISEASE | Drug-Eluting Stents | Prospective Studies | Double-Blind Method | Hemorrhage - epidemiology | Humans | Middle Aged | Male | Risk | Ticlopidine - analogs & derivatives | Angioplasty, Balloon, Coronary | Dose-Response Relationship, Drug | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Cardiovascular Diseases - mortality | Ticlopidine - administration & dosage | Female | Aged | Myocardial Infarction - prevention & control | Platelet Activation - drug effects | Platelet Aggregation - drug effects | Hemorrhage - chemically induced | Thrombosis - prevention & control | Heart attacks | Angioplasty | Mortality | Clinical trials | Drug therapy | Drug dosages | Thrombosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI: A Meta-analysis
by Mega, Jessica L and Simon, Tabassome and Collet, Jean-Philippe and Anderson, Jeffrey L and Antman, Elliott M and Bliden, Kevin and Cannon, Christopher P and Danchin, Nicolas and Giusti, Betti and Gurbel, Paul and Horne, Benjamin D and Hulot, Jean-Sebastian and Kastrati, Adnan and Montalescot, Gilles and Neumann, Franz-Josef and Shen, Lei and Sibbing, Dirk and Steg, P. Gabriel and Trenk, Dietmar and Wiviott, Stephen D and Sabatine, Marc S
JAMA, ISSN 0098-7484, 10/2010, Volume 304, Issue 16, pp. 1821 - 1830
CONTENT Clopidogrel, one of the most commonly prescribed medications, is a prodrug requiring CYP450 biotransformation. Data suggest its pharmacologic effect... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | RESPONSIVENESS | MYOCARDIAL-INFARCTION | TASK-FORCE | STENT THROMBOSIS | OF-FUNCTION POLYMORPHISM | PHARMACODYNAMICS | PRASUGREL | ASSOCIATION | PLATELET REACTIVITY | Pharmacogenetics | Thrombosis - chemically induced | Ticlopidine - therapeutic use | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Genotype | Male | Risk | Treatment Outcome | Ticlopidine - analogs & derivatives | Angioplasty, Balloon, Coronary | Cytochrome P-450 CYP2C19 | Ticlopidine - adverse effects | Ticlopidine - metabolism | Acute Coronary Syndrome - therapy | Female | Cardiovascular Diseases - chemically induced | Platelet Aggregation Inhibitors - metabolism | Platelet Aggregation Inhibitors - therapeutic use | Stents | Platelet Aggregation Inhibitors - adverse effects | Drugs | Angioplasty | Medical treatment | Cardiovascular disease | Patients | Clinical outcomes | Meta-analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Evaluation of dose-related effects of aspirin on platelet function: Results from the aspirin-induced platelet effect (ASPECT) study
by Gurbel, Paul A and Bliden, Kevin P and DiChiara, Joseph and Newcomer, Justin and Weng, Willy and Neerchal, Nagaraj K and Gesheff, Tania and Chaganti, Srivasavi K and Etherington, Amena and Tantry, Udaya S
Circulation, ISSN 0009-7322, 06/2007, Volume 115, Issue 25, pp. 3156 - 3164
Background - The antiplatelet effect of aspirin is attributed to platelet cyclooxygenase-1 inhibition. Controversy exists on the prevalence of platelet... 
Aggregation | Resistance | Aspirin | Platelets | Coronary disease | STROKE | coronary disease | CARDIAC & CARDIOVASCULAR SYSTEMS | CLOPIDOGREL | PROFILE | EFFICACY | BIOSYNTHESIS | aspirin | PERIPHERAL VASCULAR DISEASE | aggregation | platelets | resistance | Prospective Studies | Humans | Middle Aged | Male | Dose-Response Relationship, Drug | Flow Cytometry | Platelet Aggregation Inhibitors - pharmacology | Adult | Female | Aspirin - therapeutic use | Collagen - pharmacology | Platelet Aggregation - drug effects | Aspirin - pharmacology | Blood Platelets - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Drug Resistance | Cyclooxygenase 1 - blood | Coronary Disease - blood | Nephelometry and Turbidimetry | Thrombelastography | Double-Blind Method | Platelet Function Tests - methods | Platelet Glycoprotein GPIIb-IIIa Complex - analysis | Thromboxane B2 - analogs & derivatives | Adenosine Diphosphate - pharmacology | Cyclooxygenase Inhibitors - pharmacology | Cross-Over Studies | Thromboxane B2 - urine | Arachidonic Acid - pharmacology | Physiological aspects | Usage | Drug therapy | Coronary heart disease | Patient outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events: A Systematic Review and Meta-analysis
by Holmes, Michael V and Perel, Pablo and Shah, Tina and Hingorani, Aroon D and Casas, Juan P
JAMA, ISSN 0098-7484, 12/2011, Volume 306, Issue 24, pp. 2704 - 2714
CONTEXT The US Food and Drug Administration recently recommended that CYP2C19 genotyping be considered prior to prescribing clopidogrel, but the American Heart... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | GENE VARIANTS | STENT THROMBOSIS | OF-FUNCTION POLYMORPHISM | CLINICAL-EFFICACY | REACTIVITY | ANTIPLATELET TREATMENT | TREATED PATIENTS | PROTON-PUMP INHIBITORS | GENOME-WIDE ASSOCIATION | Hemorrhage - epidemiology | Ticlopidine - pharmacology | Ticlopidine - therapeutic use | Humans | Aryl Hydrocarbon Hydroxylases - genetics | Genotype | Risk | Ticlopidine - analogs & derivatives | Angioplasty, Balloon, Coronary | Randomized Controlled Trials as Topic | Cytochrome P-450 CYP2C19 | Platelet Function Tests | Ticlopidine - adverse effects | Ticlopidine - metabolism | Cardiovascular Diseases - epidemiology | Platelet Aggregation Inhibitors - pharmacology | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - metabolism | Thrombosis - prevention & control | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Genotype & phenotype | Systematic review | Cardiovascular disease | Genetic testing | Meta-analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue‐type plasminogen activator in trauma patients
by Moore, H. B and Moore, E. E and Chapman, M. P and Gonzalez, E and Slaughter, A. L and Morton, A. P and D'Alessandro, A and Hansen, K. C and Sauaia, A and Banerjee, A and Silliman, C. C
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 10/2015, Volume 13, Issue 10, pp. 1878 - 1887
Summary Background Systemic hyperfibrinolysis is a lethal phenotype of trauma‐induced coagulopathy. Its pathogenesis is poorly understood. Recent studies have... 
fibrinolysis | trauma | fibrinogen | blood platelet disorder | platelet function tests | Platelet function tests | Blood platelet disorder | Fibrinolysis | Trauma | Fibrinogen | SEVERE INJURY | BILE-SALTS | FIBRINOLYSIS SHUTDOWN | HEMORRHAGIC-SHOCK | HYPERFIBRINOLYSIS | ACUTE COAGULOPATHY | FACTOR-XIII | COAGULATION | PERIPHERAL VASCULAR DISEASE | ANTIFIBRINOLYTIC THERAPY | HEMATOLOGY | CLOT STRENGTH | Fibrinolysis - drug effects | Multivariate Analysis | Predictive Value of Tests | Prospective Studies | Blood Viscosity | Humans | Middle Aged | Elasticity | Male | Tissue Plasminogen Activator - therapeutic use | Injury Severity Score | Patient Selection | Adenosine Diphosphate - blood | Calcium - blood | Fibrinolytic Agents - therapeutic use | Platelet Function Tests | Thrombolytic Therapy - methods | Adult | Female | Blood Platelets - drug effects | Wounds and Injuries - blood | Linear Models | Treatment Outcome | Biomarkers - blood | Blood Platelets - metabolism | Fibrinogen - metabolism | Wounds and Injuries - diagnosis | Wounds and Injuries - drug therapy | Measurement | Medicine, Experimental | Medical research | Fibrin | Analysis | Viscoelasticity | Pathogenesis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance"
by Santilli, Francesca and Rocca, Bianca and De Cristofaro, Raimondo and Lattanzio, Stefano and Pietrangelo, Laura and Habib, Aida and Pettinella, Caterina and Recchiuti, Antonio and Ferrante, Elisabetta and Ciabattoni, Giovanni and Davì, Giovanni and Patrono, Carlo
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2009, Volume 53, Issue 8, pp. 667 - 677
Objective: This study was conducted to assess the thromboxane (TX) dependence of biochemical and functional indexes used to monitor the effect of low-dose... 
aspirin | prostaglandins | antiplatelet drugs | platelets | pharmacology | STROKE | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | THERAPY | ATHEROTHROMBOSIS | HEALTHY-SUBJECTS | THROMBOXANE | BIOSYNTHESIS | CARDIOVASCULAR-DISEASE | PREVENTION | RISK | Thromboxane B2 - metabolism | Humans | Cyclooxygenase Inhibitors - administration & dosage | Male | Thrombopoietin - blood | Adenosine Diphosphate - pharmacology | Aspirin - administration & dosage | Young Adult | Blood Platelets - cytology | Blood Platelets - metabolism | Platelet Aggregation Inhibitors - administration & dosage | Cyclooxygenase 2 - metabolism | Platelet Function Tests | Adult | Female | Platelet Aggregation - drug effects | Blood Platelets - drug effects | Drug Resistance | Aspirin | Blood platelets | Womens health | Collagen | Software | Nonsteroidal anti-inflammatory drugs | Drug therapy | Variance analysis | Drug dosages
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights